Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides.
about
Sensors of Infection: Viral Nucleic Acid PRRs in FishSteps to translate preconditioning from basic research to the clinicKnocking down disease: a progress report on siRNA therapeuticsThe effect of TLR9 agonist CpG oligodeoxynucleotides on the intestinal immune response of cobia (Rachycentron canadum).Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity.Spontaneous production of immunoglobulin M in human epithelial cancer cellsHuman NLRP3 inflammasome senses multiple types of bacterial RNAs.Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 bindingDesign and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703.Traditional biochemical assays for studying toll-like receptor 9.Targeting the innate immune response with improved vaccine adjuvants.Innate immune recognition of nucleic acids: beyond toll-like receptors.Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.Development of murine plasmacytoid dendritic cell subsets.DEC-205 is a cell surface receptor for CpG oligonucleotides.CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production.Toll-like receptor 9 interaction with CpG ODN--an in silico analysis approachThe significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence.Immunogenicity of intrathecal plasmid gene delivery: cytokine release and effects on transgene expressionStructural requirements and applications of inhibitory oligodeoxyribonucleotides.Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha.Review: variability of host-pathogen interaction.Therapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulation.Toll-like receptor 9-dependent activation of myeloid dendritic cells by Deoxynucleic acids from Candida albicans.T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes.The mononuclear phagocyte system of the pig as a model for understanding human innate immunity and disease.Nucleic acids exert a sequence-independent cooperative effect on sequence-dependent activation of Toll-like receptor 9.Extended sequence preferences for oligodeoxyribonucleotide activity.CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA.The effects of CpG-ODNs and Chitosan adjuvants on the elicitation of immune responses induced by the HIV-1-Tat-based candidate vaccines in mice.DNAzyme targeting c-jun suppresses skin cancer growth.B cells do not take up bacterial DNA: an essential role for antigen in exposure of DNA to toll-like receptor-9.Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apoptosis, proliferation, and potentiation of chemotherapy.Inhibitory effects of unmethylated CpG oligodeoxynucleotides on MHC class I-deficient and -proficient HPV16-associated tumours.Selectivity of Human TLR9 for Double CpG Motifs and Implications for the Recognition of Genomic DNA.Activation of TLR9 by incorporated pDNA within PEG-coated lipoplex enhances anti-PEG IgM production.Characterization of Rabbit Nucleotide-Binding Oligomerization Domain 1 (NOD1) and the Role of NOD1 Signaling Pathway during Bacterial Infection.RNA-targeted suppression of stress-induced allostasis in primate spinal cord neurons.
P2860
Q26799867-AC6F8F60-21BE-45B9-AEED-8A7105169445Q26995931-07461BD9-8D21-45B5-B6C4-42AB7DAE2FC9Q28082939-1B485570-D6CA-48E5-AF01-17D532C54575Q31171481-767713B0-B77C-46E7-924E-32E4B7BD8F9BQ34341859-D52DBDF3-7E81-4597-A901-E722D7A01FB6Q34516619-88E6FC8D-B42F-49BE-B9A9-12426287CCA9Q34526089-32BFE125-14AB-46F7-AF5F-DDFD47374344Q34647633-EB29C508-6D71-4DC4-BFE2-161CE1E759BDQ35635250-F9493F1F-2E7B-4E40-9CE8-03F43228D0FBQ35671392-DB5251AE-C22A-476A-A031-AD3B1AAACC65Q36090194-5D7A4D6D-2E35-4CFD-AC97-5BE8D06B2FD1Q36218382-36292636-9F5F-40D6-AF6B-35B3EF33C1D4Q36229655-CC9A27B5-AD41-4C76-B865-BDCB52F7C7E9Q36262296-6347678B-DD4C-4CC5-8628-B7B0CAF3368DQ36343007-27E3854D-0382-408D-BB75-013566D2A4D9Q36378325-7FA9D0A3-CAD9-4331-BA38-10A9D094840AQ36698058-2430D2E7-5BB1-48E9-8ACF-F4C162531F29Q36751712-88DE5FD9-3D14-4CCB-A128-CD8F948C3CE7Q36831409-31689DCB-9C22-4977-A9B3-DF4F88EDE24EQ36961012-2C69638D-908F-402A-9C56-26B399D969FCQ36976468-B8D70C7E-7C1D-407A-9F7E-7C7F88745492Q36980187-6C5B2A52-E944-4869-9EEF-2604E57CC174Q37004584-54DB88B8-DD61-411D-939E-CC5C85ABD718Q37256585-FDDA2FD3-A9C1-4CFA-B3ED-4B9075012A52Q37334065-168B0396-3046-4F1C-B29F-FF3680364A61Q37643323-9E8698B5-C976-4E8C-AC87-FAE7AA13778FQ37828326-E8015DAA-F072-4326-AE61-BFB2CE4E3431Q38303750-BF23708D-B9FC-485F-8CBE-EBCBC0A162F5Q38314811-97064D10-FFDB-486E-9C99-05A5C8FF1E1AQ38316638-C173EC06-D5FD-4EBC-A5AB-74E92938D1B9Q38973146-05303A5A-3219-4A36-A991-B41AFCF74F59Q39326899-B8625A9C-4940-42EA-B169-AEF509FEB396Q39648141-9E3D1F4F-E38F-47B8-A1BE-DD295258DBF9Q40156604-2BD8EACB-C3F8-443E-9B9C-20956DF62D75Q40240567-6B14F1E2-72C0-41E6-B41C-9A94368F5100Q40363279-DC7B0A8F-87A2-4822-864E-0107FFEC571EQ40367593-F1CDE8AC-C745-4FF3-B66C-3809D055FD4DQ42227407-19269075-6331-4372-9660-A91BC0A66DA0Q42654147-F4647C5E-4C40-4253-A46E-5950D35E4714Q51629436-7A00B110-1729-4E46-8276-81672F2E1883
P2860
Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cutting edge: species-specific ...... ate-modified oligonucleotides.
@en
type
label
Cutting edge: species-specific ...... ate-modified oligonucleotides.
@en
prefLabel
Cutting edge: species-specific ...... ate-modified oligonucleotides.
@en
P1476
Cutting edge: species-specific ...... ate-modified oligonucleotides.
@en
P2093
Katryn J Stacey
Matthew J Sweet
P304
P356
10.4049/JIMMUNOL.174.2.605
P407
P577
2005-01-01T00:00:00Z